BioSim Pro · Trusted by 400+ research institutions globally · 30-day free trial
From COVID vaccines to cancer therapies, LNPs have become the most important drug delivery platform of the decade. Here is the biology and chemistry of how they actually work — explained clearly for researchers and students.
The KEYNOTE-942 Phase III trial confirms the Phase IIb signal: adding the individualised neoantigen vaccine to pembrolizumab delivers a statistically significant improvement in recurrence-free survival versus pembrolizumab alone.
pH-responsive PLGA nanoparticles enable targeted intratumoral drug accumulation while significantly reducing systemic toxicity compared to free docetaxel administration.
The Expert Opinions category brings together insights, perspectives, and analysis from leading voices in the biomedical and healthcare industries. This section is dedicated to sharing thought leadership from researchers, clinicians, industry professionals, and innovators who are actively shaping the future
Clinical trials are the backbone of modern medicine, driving the development of new treatments, therapies, and medical technologies. In this category, we explore the latest advancements, trends, and insights shaping the world of clinical research. From early-phase studies to large-scale
Deadline: 12 May 2026
Posted 2 days ago · Full-time
Deadline: 30 April 2026
